Smoking Cessation: Treating Tobacco Dependence
|
|
- Tyler Pitts
- 6 years ago
- Views:
Transcription
1 Smoking Cessation: Treating Tobacco Dependence Pat Folan, RN Center for Tobacco Control Pulmonary Medicine NS-LIJ Health System NYS DOH Tobacco Control Program
2 Treating Tobacco Dependence Center for Tobacco Control Services Review of Clinical Practice Guideline, 2008 Update for Treating Tobacco Use and Dependence Reimbursement for counseling
3 Center for Tobacco Control Services Free Community Smoking Cessation Program, and follow up support group at our center in Great Neck Employee Program for all NS-LIJ Health System Employees including all cessation medications Medco also covers all cessation medications with no co-pay (OTC and RX for covered employees and dependents) Healthcare Provider education and support throughout Long Island Free 21 credit CME performance improvement project
4 Current Statistics Tobacco related illness is the leading cause of preventable death in the U.S., killing over 440,000 annually (CDC 2005) 70% of all tobacco users want to quit (CDC 2002) Quit attempts are 30% more successful with advice/support from a HCP (PHS Guideline: Treating Tobacco Use and Dependence 2008)
5 Prevalence 20.9% of adults smoke in the U.S. (CDC 2005) Prevalence rate is 18.3% in NYS (RTI 2006) Goal of Healthy People 2010 is to reduce smoking to 12% of adults by 2010 (USDHHS 2005)
6 The 5 A s Public Health Service-sponsored Clinical Practice Guideline, Treating Tobacco Use and Dependence (2008) Developed by Agency for Healthcare Research and Quality (AHRQ) ASK ADVISE ASSESS ASSIST ARRANGE
7 The 5 R sr Relevance Risks Rewards Roadblocks Repetition USDHHS PHS Guideline 2008
8 The Pharmacological Approach to Treating Nicotine Dependence
9 Nicotine The main adverse effect of nicotine is addiction, which sustains tobacco use. Nicotine dependence leads to continued exposure to toxins in tobacco smoke.
10 Neurochemical Effects of Nicotine Nicotine Dopamine Norepinephrine Acetylcholine Glutamate Serotonin ß-endorphin Pleasure Appetite Suppression Arousal, Cognitive Enhancement Memory Mood Modulation Anxiety Reduction Benowitz NL. Primary Care. 1999; 26: 619.
11 First Line Therapies Buproprion SR Varenicline Nicotine gum-otc Nicotine inhaler Nicotine nasal spray Nicotine patch-otc Nicotine lozenge-otc Second Line Therapies Clonidine severe hypotension Nortriptyline fatal in overdose (These drugs are rarely used)
12 Cessation Medications Bupropion NRT Varenicline Bupropion and NRT
13 Bupropion Wellbutrin SR, Zyban Acts on receptor sites - nucleus accumbens Pregnancy Category (Class C)
14 Bupropion Dosing SR formulation (ZYBAN) 150 mg one daily for 3 days, then 150 mg twice a day XL formulation (Wellbutrin( XL) mg once a day (off label use) Start weeks before quit date. Duration of therapy is weeks
15 Bupropion Contraindications Seizure disorder or any potential for seizures Eating disorder MAO inhibitor in past 14 days
16 Side Effects Insomnia (35-40%) Less with XL formulation Dry mouth (10%) Seizure (1 in 1000) Depression, suicidal ideation, suicide attempt, and completed suicide
17 Varenicline Chantix Α4β2 2 nicotinic subtype acetylcholine receptor (nachr( nachr) ) partial agonist Also works as a nicotine antagonist- reduces the pleasurable effect of smoking
18 Starter Pack: Dosing 0.5 mg daily for 3 days 0.5mg twice daily for 4 days 1mg twice daily- maintenance dose Duration of therapy 12 weeks can continue 12 additional weeks if successfully quit Not recommended for use with NRT (may increase nausea and side effects)
19 Varenicline Decrease dose in renal impairment Side effects: nausea (30%) Lower dose, take with food, fluids 10% reported headache, insomnia, abnormal dreams depression, suicidal ideation, suicide attempt and completed suicide angioedema, Stevens-Johnson Syndrome, erythema multiforme traffic accidents, accidental injuries, loss of consciousness
20 Nicotine Replacement Therapy
21 Nicotine Replacement Therapy (NRT) Helps relieve withdrawal symptoms Provides lower nicotine levels than smoking Doubles chance of success versus placebo Safe, effective Fiore MC, Bailey WC, Cohen SJ, et al. Treating Tobacco Use and Dependence. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service. June 2000.
22 Increase in nicotine concentration ( ng/ml ) Plasma nicotine concentrations for smoking and NRT Minutes Source: Balfour DJ & Fagerström KO. Pharmacol Ther : Cigarette Gum 4 mg Gum 2 mg Inhaler Nasal spray Patch
23 Nicotine Patch Features Transdermal delivery system provides regulated, constant level of nicotine Convenient and well tolerated, with low dependency potential
24 Nicotine Patch Dosing 1 patch/day worn for 16 or 24 hours daily Available doses range from mg/patch Dosing according to amount smoked Step 1 patch Step 2 patch Step 3 patch Smoking 1 PPD or more Smoking ½ to 1PPD Smoking less than ½ PPD Step down every 6 weeks
25 Nicotine Patch Side effects Local: skin irritation, rash More marked reactions with 24-hour patch Rotate sites, hydrocortisone cream may help Systemic: insomnia, sleep disturbances, dyspepsia To limit sleep disturbances, remove the patch 1 hour before bedtime
26 Nicotine Gum / Lozenge Features Nicotine absorbed via buccal mucosa Available in 2 mg and 4 mg strengths 4 mg strength more effective for highly addicted (>25 cigarettes per day) smokers Self-titration
27 Nicotine Gum or Lozenge Dosing Use at least 9 pieces/day during first 6 weeks Technique critical to correct use Chew or moisten and then park Avoid alcohol and caffeinated beverages Side effects Local: irritation of tongue, mouth and throat, ulceration of oral mucosa, jaw-muscle ache Systemic: indigestion, nausea, dizziness
28 Nicotine Inhaler Dosing Individualized-self titration Initial treatment can range from weeks For best results, use up to 16 cartridges/day for first 3 to 6 weeks If needed, gradual reduction can begin after initial treatment period Rx: 1box = 168 cartridges
29 Nicotine Nasal Spray Intranasal delivery with fast, effective relief of withdrawal symptoms Designed for ad libitum use with dose flexibility Particularly beneficial for highly dependent smokers or those not responding to other treatments Rx only: 1 box = 4 bottles
30 Dosing Nicotine Nasal Spray 1 spray each nostril (2 sprays = 1 mg nicotine) Do not exceed 5 doses/hr or 40 doses/day (usually much less is needed) Side effects Nasal irritation, runny nose, throat irritation, watering eyes, sneezing and coughing Tolerability occurs after a couple days
31 Combination Therapy There is evidence that combining the nicotine patch with bupropion SR, or the nicotine patch with nicotine gum, nasal spray or inhaler increases long-term abstinence rates. Fiore MC, Jaen CR, Baker, TB, et al. Treating Tobacco Use and Dependence.. Clinical Practice Guideline 2008 Update. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service.
32 Long-term Pharmacotherapy Goal of long-term pharmacotherapy is to replace smoking Long-term use of NRT and bupropion is likely to be much safer than smoking but efficacy has not yet been demonstrated Experience with long term bupropion use for depression suggests it is well tolerated
33 Is NRT suitable for cardiovascular pts? No evidence of increased CV risk with NRT NRT delivers plasma cotinine levels far below those produced by smoking NRT causes less vasospasm than smoking There is no data to support that NRT causes acute cardiovascular events
34 AHA s Position Statement on NRT NRT has been shown to be safe and effective in helping people stop using cigarettes when used as part of a comprehensive smoking cessation program. NRT has been shown to be safe in most people with Heart Disease. accessed 07/25/2009
35 Billing for Smoking and Tobacco-Use Cessation Counseling 2009
36 Billing Codes for Tobacco Cessation Counseling CPT Code Billing Code Definition Smoking and tobacco use cessation counseling visit; intermediate, greater than 3 minutes up to 10 minutes Smoking and tobacco use cessation counseling visit; intensive, greater than 10 minutes Counseling for 3 minutes or less is considered part of the evaluation & management (E&M) service and cannot be billed as an additional service.
37 Coverage Coverage Frequency 2 tobacco cessation attempts are covered annually Each attempt has maximum of 4 sessions 8 counseling sessions in a 12 months period Eligibility for Coverage Patient has adverse health affect from tobacco use or Patient treated with a therapeutic agent whose metabolism or dosing is affected by tobacco use
38 Required Documentation Patient history must be sufficient to demonstrate coverage conditions were met Diagnosis code must reflect Condition that is adversely affected by tobacco use Condition being treated with a therapeutic agent whose metabolism or dosing is affected by tobacco use Time spent Intervention recommended
39 Other Reimbursement Some public and private sector Managed Care Organizations also provide smoking cessation benefits Benefits vary nationwide check patient s health insurance provider benefits; ask about coverage
40 Cessation Medication Medicaid Benefit Package NYS Covered Meds Nicotine Nasal Spray, Zyban, Nicotine Inhalers, Varenicline, Nicotine patches and gum 2 courses of therapy per patient per year 1 course = 90 day supply Combination Therapy permitted- must have Rx for all meds. NYS,
41 NYS Medicaid Coverage Smoking cessation counseling for Medicaid eligible pregnant women (1/1/09) 6 sessions in 12 month period By MDs, PAs, NPs, midwives At hospital outpatient depts., diagnostic and treatment centers, and federally qualified health centers. NYS DOH Office of Health Insurance Programs, 2009
42 Multi-State Collaborative for Health Systems Change Mission Statement: We are a collaborative of tobacco control programs working to facilitate sustainable changes in healthcare systems within our states and nationally in order to reduce tobacco use and prevalence.
43 Task Group Insurance and Reimbursement Increase in provision of comprehensive cessation benefits to all members Increase reimbursement for provision of evidence-based direct cessation services Information sharing: Medicaid reimbursement for counseling and pharmacotherapy
44 Members New York Wisconsin Iowa New Hampshire Massachusetts Rhode Island Minnesota Vermont Colorado Maine Washington Oregon Ohio
45 THANK YOU! Pat Folan, RN Center for Tobacco Control
IMPORTANT POINTS ABOUT MEDICATIONS
IMPORTANT POINTS ABOUT MEDICATIONS The U.S. Food & Drug Administration (FDA) advises that there are significant health benefits to quitting smoking. The health benefits of quitting smoking include a reduction
More informationPharmacologic Therapy for Tobacco Use & Dependence
Pharmacologic Therapy for Tobacco Use & Dependence Thomas Gauvin, MA, TTS Mayo Clinic Nicotine Dependence Center Rochester, MN 2013 MFMER slide-1 Learning Objectives Understand the 7 first line medications
More informationSmoking cessation therapy
Appendix 1 Smoking cessation therapy Q. Can a dentist prescribe medications for smoking cessation? A. Yes. Dentists are allowed and are encouraged to help patients with smoking cessation by counseling
More informationTobacco Dependence Screening and Treatment in Behavioral Health Settings. Prescribing
Tobacco Dependence Screening and Treatment in Behavioral Health Settings Prescribing GOAL To build the capacity of prescribing clinicians in behavioral health settings to integrate best practices for prescribing
More informationPharmacotherapy for Treating Tobacco Dependence
Pharmacotherapy for Treating Tobacco Dependence Sheila K. Stevens, MSW Education Coordinator Nicotine Dependence Center 2013 MFMER slide-1 Rationale for Pharmacological Therapy Success rate doubles Manage
More informationPHARMACOTHERAPY OF SMOKING CESSATION
PHARMACOTHERAPY OF SMOKING CESSATION Domenic A. Ciraulo, MD Director of Alcohol Pharmacotherapy Research Center for Addiction Medicine Department of Psychiatry Massachusetts General Hospital Disclosure
More informationNicotine Replacement and Smoking Cessation: Update on Best Practices
Nicotine Replacement and Smoking Cessation: Update on Best Practices Adrienne Duckworth, MSN, APRN, FNP-C, CTTS Section of Hematology/Oncology WVU Department of Medicine WVU Cancer Institute Objective
More informationAddressing Tobacco Use in Iowa
Addressing Tobacco Use in Iowa A BRIEF TOBACCO INTERVENTION FOR HEALTHCARE PROVIDERS Lorene Mein Beth Turner Alyssa Reichelt DNP, ARNP, FNP-BC MA, CHES MA Mercy Clinics American Lung Association American
More informationMedication Management to Aid in Smoking Cessation. Rachel Constant, Pharm.D. Baptist Health Corbin Pharmacy Resident 3/22/2019
Medication Management to Aid in Smoking Cessation Rachel Constant, Pharm.D. Baptist Health Corbin Pharmacy Resident 3/22/2019 1 Learning Objectives: Review the prevalence of tobacco use. Describe tools
More informationSmoking Cessation and the Pharmacist
Smoking Cessation and the Pharmacist Jennifer Roberts Assistant Director, Research Pharmacy 1 Objectives Review smoking cessation medication use, based on public health guidelines, as well as contraindications
More informationCessation Medicine Reference Guide Table of Contents
Cessation Medicine Reference Guide Table of Contents 1. Patch 2. Nicotine Gum 3. Nicotine Lozenge 4. Inhaler 5. Nasal Spray 6. Bupropion SR (Zyban) 7. Chantix (Varenicline) Patch Typical course of therapy
More informationHIV and Aging. Making Tobacco Cessation a Priority in HIV/AIDS Services. Objectives. Tobacco Use Among PLWHA
HIV and Aging Making Tobacco Cessation a Priority in HIV/AIDS Services June 27, 2008 Amanda Brown, MPH Ruth Tripp, MPH, RN Objectives To explore existing knowledge of the HIV and smoking connection. To
More informationMy Mask. I keep it all inside. Because I d rather. The pain destroy me. Than everyone else. Anon.
My Mask KL I keep it all inside Because I d rather The pain destroy me Than everyone else. Anon. 43 K. N. Roy Chengappa, M.D., FRCPC Professor of Psychiatry, University of Pittsburgh School of Medicine,
More informationPharmacotherapy Summary for the Treatment of Nicotine Withdrawal and Nicotine Dependence 1
Pharmacotherapy Summary for the Treatment of Nicotine Withdrawal and Nicotine Dependence 1 Compiled by: TOP, in collaboration with Dr. Charl Els and Mr. Ron Pohar: TRaC II (Alberta Medical Association/Primary
More informationNYSMPEP Smoking Cessation Guidance: Key Message 3
NYSMPEP Smoking Cessation Guidance: Key Message 3 Key Message 3: All smokers trying to quit should be offered medication (except when contraindicated or for specific populations). The Agency for Healthcare
More informationSMOKING CESSATION. Recommendations 5As Approach to Smoking Cessation. Stages of Change Assisting the Smoker. Contributor Dr. Saifuz Sulami.
SMOKING CESSATION 08 Recommendations 5As Approach to Intervention Stages of Change Assisting the Smoker Pharmacotherapy Contributor Dr. Saifuz Sulami Advisor Dr. Audrey Tan 79 nhg_guideline_14102010_1112.indd
More informationSmoke-free Hospitals. Linda A. Thomas, MS University of Michigan Health System Tobacco Consultation Service
Smoke-free Hospitals Linda A. Thomas, MS University of Michigan Health System Tobacco Consultation Service Today s Subjects 5A s and Clinician Training and Use with the Hospitalized Patient NRT use in
More information1. Describe the benefits of smoking cessation. 2. List the withdrawal symptoms of quitting smoking. Cessation
Time to Butt Out Adil Virani, BSc (Pharm), Pharm D, FCSHP Objectives After this presentation, participants should be able to: 1. Describe the benefits of smoking cessation 2. List the withdrawal symptoms
More informationEffective Treatments for Tobacco Dependence
Effective Treatments for Tobacco Dependence Abigail Halperin MD, MPH Director, University of Washington Tobacco Studies Program Ken Wassum Associate Director of Clinical Development and Support Quit for
More informationBest Practice for Smoking Cessation: Pharmacotherapy. Emma Dean Acting Population Health and Health Promotion Coordinator Lead Pharmacist- Smokefree
Best Practice for Smoking Cessation: Pharmacotherapy Emma Dean Acting Population Health and Health Promotion Coordinator Lead Pharmacist- Smokefree Why is it so hard to quit? People who smoke aren t weak
More informationDisclaimers. Smoking and Smoking Cessation. Worldwide. Objectives. Statistics at Home. Smoking Epidemic 16/10/2017
Disclaimers Smoking and Smoking Cessation Dr. Janneke Gradstein CCFP(EM) Yarmouth, NS Received CHA Funding 6 th Annual Ottawa Conference: State of the Art Clinical Approaches to smoking cessation. References
More information5. Offer pharmacotherapy to all smokers who are attempting to quit, unless contraindicated.
0 11 Key Messages 1. Ask and document smoking status for all patients. 2. Provide brief advice on quit smoking at every visit to all smokers. 3. Use individual, group and telephone counselling approaches,
More informationTREATMENT INTERVENTIONS
SMOKING CESSATION TREATMENT INTERVENTIONS Smoking and Health Tobacco is the single most preventable cause of death in the world today. kills more than five million people By 2030, the death toll will exceed
More information3. Chantix [package insert]. New York, NY: Pfizer, Inc,; Ramon JM, Morchon S, Baena A, Masuet-Aumatell C. Combining varenicline and nicotine
How can there be a warning regarding concomitant use of varenicline with nicotine replacement therapy yet patients can be on varenicline and smoke concurrently? April 20, 2017 The United States (US) Preventive
More informationMEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE
MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Smoking Cessation Products LAST REVIEW 5/8/2018 THERAPEUTIC CLASS: Psychiatric Disorders REVIEW HISTORY 5/17, 5/16, 5/15,
More informationSMOKING CESSATION WORKSHOP. Dr Mark Palayew December
SMOKING CESSATION WORKSHOP Dr Mark Palayew December 5 2016 Conflicts of Interest None Case 1 Mr. T is a 55 year old smoker 2 packs/day He has been smoking continuously since age 16 When he wakes up at
More informationSmoking Cessation Strategies: What Works?
Smoking Cessation Strategies: What Works? Andrew M. Busch, Ph.D. Centers For Behavioral and Preventive Medicine The Miriam Hospital Department of Psychiatry and Human Behavior Alpert Medical School of
More informationBackground. Abstinence rates associated with varenicline
What are the range of abstinence rates for varenicline for smoking cessation? Do they differ based on treatment duration? Are there any studies utilizing 3-4 months of varenicline treatment? Background
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Policy: Smoking Cessation Products Reference Number: TCHP.PHAR.18002 Effective Date: 01.01.19 Last Review Date: 10.12.18 Line of Business: Oregon Health Plan Revision Log See Important Reminder at the
More informationOutpatient Tobacco Addiction Treatment Pathway Additional Notes
Outpatient Tobacco Addiction Treatment Pathway Additional Notes First Line: Varenicline (provide in conjunction with counselling/support, but if such support is refused or is not available, this should
More informationKeywords: tobacco, cigarette smoke, nicotine, dopamine, smoking cessation, acethylcholine, varenicline (champix )
Review Article and Clinical Experience: ENICLINE (CHAMPIX ) : A BREAKTHROUGH FOR SMOKING CESSATION TREATMENT (An α4ß2 Nicotinic Acethylcholine Receptor Partial Agonist) Askandar Tjokroprawiro Diabetes
More informationVarenicline and Other Pharmacotherapies for Tobacco Dependence
Varenicline and Other Pharmacotherapies for Tobacco Dependence J. Taylor Hays, M.D. Associate Director Nicotine Dependence Center Mayo Clinic 2012 MFMER slide-1 Learning Objectives Understand the mechanism
More informationNicotine Replacement Therapy, Zyban and Champix. Name of presentation
Nicotine Replacement Therapy, Zyban and Champix Nicotine Replacement Therapy (NRT) - Rationale for use Nicotine is highly addictive and causes unpleasant withdrawal symptoms which often undermine a quit
More informationTobacco & Nicotine: Addiction and Treatment
Tobacco & Nicotine: Addiction and Treatment Tim McAfee, MD, MPH Chief Medical Officer - Free & Clear 206-876-2551 - tim.mcafee@freeclear.com Affiliate Assistant Professor, University of Washington, School
More informationHelping People Quit Tobacco
Helping People Quit Tobacco Peter Selby MBBS, CCFP, MHSc, ASAM Associate Professor, University of Toronto Clinical Director, Addictions Program, CAMH Principal Investigator, OTRU Disclosures! Grants/research
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Reference Number: CP.CPA.113 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Commercial Revision Log See Important Reminder at the end of this policy for important regulatory
More informationSave Lives and Money. Help State Employees Quit Tobacco
Save Lives and Money Help State Employees Quit Tobacco 2009 Join These 5 Leading States Cover All the Treatments Your State Employees Need To Quit Tobacco 1 2 Follow these leaders and help your state employees
More informationTREATMENT OF NICOTINE DEPENDENCE
TREATMENT OF NICOTINE DEPENDENCE Introduction Most commonly used substance the world over. Largest cause of preventable death worldwide. Leading causes of smoking related death Cardiovascular diseases
More informationWanting to Get Pregnant
Continuing Medical Education COPD Case Presentation LEARNING OBJECTIVES Those completing this activity will receive information that should allow them to Assist a patient in developing a quit plan; Advise
More informationSmoking Cessation Services Guidance
Smoking Cessation Services Guidance Alabama Medicaid Tobacco Treatment Coverage Covered Services/Medication 1. Free tobacco cessation counseling is provided through the Alabama Tobacco Quitline. Refer
More informationTobacco Cessation The Role of the Dentist/Oral Medicinist
Tobacco Cessation The Role of the Dentist/Oral Medicinist Jennifer Frustino, DDS PhD Oral Oncology & Maxillofacial Prosthetics Erie County Medical Center Buffalo, NY Statement of Disclosure I have no actual
More informationSt. Joseph s Health PROVIDER BRIEF. Tobacco Dependence Treatment Guidelines Perinatal and Postpartum Women
St. Joseph s Health PROVIDER BRIEF Tobacco Dependence Treatment Guidelines Perinatal and Postpartum Women Quitting smoking is perhaps the most important action a pregnant woman can do to ensure the health
More informationPharmacologic Therapy for Tobacco Use & Dependence Nicotine Replacement Therapy (NRT) and Bupropion
Pharmacologic Therapy for Tobacco Use & Dependence Nicotine Replacement Therapy (NRT) and Bupropion Jennifer Bluem Moran, MA, TTS Mayo Clinic Nicotine Dependence Center Rochester, MN 2013 MFMER slide-1
More informationOver the Road Truck Driver Who Smokes
Continuing Medical Education Case Presentation 1 CME Credit Physicians Physician Assistants Nurse Practitioners Over the Road Truck Driver Who Smokes RELEASE & REVIEW DATE This activity was last reviewed
More informationManagement of Perinatal Tobacco Use
Management of Perinatal Tobacco Use David Stamilio, MD, MSCE Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, UNC School of Medicine Funding for this project is provided in
More informationTobacco Cessation: Best Practices in Cancer Treatment. Audrey Darville, PhD APRN, CTTS Certified Tobacco Treatment Specialist UKHealthCare
Tobacco Cessation: Best Practices in Cancer Treatment Audrey Darville, PhD APRN, CTTS Certified Tobacco Treatment Specialist UKHealthCare Objectives 1. Describe the current state of tobacco use treatment
More informationThe Kentucky Department for Public Health University of Kentucky College of Nursing Local Health Department Tobacco Cessation Survey, 2006
The Kentucky Department for Public Health University of Kentucky College of Nursing Local Tobacco Cessation Survey, 2006 Health Department Report prepared through a contract between the Kentucky Cabinet
More informationCounseling the Tobacco Dependent Patient. Gretchen Whitby, CNP The Lung Center
Counseling the Tobacco Dependent Patient Gretchen Whitby, CNP The Lung Center http://www.surgeongeneral.gov/tobacco/treating_tobacco_use08.pdf Tobacco Dependence Tobacco dependence is a chronic disease
More informationTB and Tobacco: Pharmacotherapy for Tobacco. Cessation. Cathy Cook, LCSW, CTTS
TB and Tobacco: Pharmacotherapy for Tobacco Cessation Cathy Cook, LCSW, CTTS Objectives 1. Describe the pharmacokinetics of nicotine to aid providers in treating TB patients who use tobacco. 2. List the
More informationTime to Butt Out. Adil Virani, BSc (Pharm), Pharm D, FCSHP
Time to Butt Out Adil Virani, BSc (Pharm), Pharm D, FCSHP Objectives After this presentation, participants should be able to: 1. Describe the benefits of smoking cessation 2. List the withdrawal symptoms
More informationBrief Intervention for Smoking Cessation. National Training Programme
Brief Intervention for Smoking Cessation National Training Programme Introduction Monitor tobacco use and prevention policies Protect people from tobacco smoke Offer help to quit tobacco use Warn about
More informationSave a Life in 3 Minutes
Save a Life in 3 Minutes Tobacco Cessation for Dental Hygiene Care Produced by Margaret J. Fehrenbach, RDH, MS 1 Not since the polio vaccine has this nation had a better opportunity to make a significant
More informationSMOKING CESSATION IS HARD
POWER TO BREAK THE HOLD OF NICOTINE ADDICTION 1 SMOKING CESSATION IS HARD Most smokers try to quit 5-7 times before they are successful. 2 Why is it so hard to quit? Typical withdrawal symptoms from stopping
More informationSmoking and Nicotine Replacement Therapy (NRT) Lec:5
Smoking and Nicotine Replacement Therapy (NRT) Lec:5 Tobacco use remains the single largest preventable cause of mortality. Cigarette smoke is a complex mixture of an estimated 4800 compounds. Approximately
More informationObjectives. Disclosure. Prevalence of Tobacco Use. Smoking Cessation Pharmacotherapy 3/2/2016.
Smoking Cessation Pharmacotherapy Melodie Merzier-Michel PGY-1 Pharmacy Resident Memorial Regional Hospital www.fshp.org Objectives Discuss the prevalence of tobacco use in the United States (U.S.) Describe
More informationSmoking Cessation: Where Are We Now? Nancy Rigotti, MD
Smoking Cessation: Where Are We Now? Nancy Rigotti, MD Director, MGH Tobacco Research and Treatment Center Professor of Medicine, Harvard Medical School nrigotti@partners.org OVERVIEW The challenge for
More informationTobacco Dependence Treatment From Neurobiology through Public Policy
Tobacco Dependence Treatment From Neurobiology through Public Policy Mary Ellen Wewers, PhD, MPH, RN Professor Emerita The Ohio State University College of Public Health Disclosures Funding from the National
More informationAfter the Last Cigarette
After the Last Cigarette Treatment Options for Quitting Tobacco By Susan Kahler, MBA, CTTS Risks from Smoking The Highly Engineered Product Nicotine Delivered by Inhalation Characteristics of Nicotine
More informationAIDS for CESSATION PHARMACOTHERAPY. METHODS for QUITTING. NONPHARMACOLOGIC METHODS (cont d) NONPHARMACOLOGIC METHODS
METHODS for QUITTING AIDS for CESSATION Nonpharmacologic Counseling and other non-drug approaches Pharmacologic FDA-approved medications Counseling and medications are both effective, but the combination
More informationAIDS for CESSATION PHARMACOTHERAPY. METHODS for QUITTING. NONPHARMACOLOGIC METHODS (cont d) NONPHARMACOLOGIC METHODS
METHODS for QUITTING AIDS for CESSATION Nonpharmacologic Counseling and other non-drug approaches Pharmacologic FDA-approved medications Counseling and medications are both effective, but the combination
More informationHow to help your patient quit smoking. Christopher M. Johnson MD, PhD
How to help your patient quit smoking Christopher M. Johnson MD, PhD Outline Smoking and its effects on IBD CD UC Clinical interventions Pharmacotherapy Resources Outline Smoking and its effects on IBD
More informationAl Heuer, PhD, RRT, RPFT Professor & Program Dir. Rutgers School of Health Related Professions
Al Heuer, PhD, RRT, RPFT Professor & Program Dir. Rutgers School of Health Related Professions Learning Objectives Review the Epidemiology and statistics regarding tobacco dependence Identify new tobacco
More informationTOBACCO CESSATION: INCORPORATING MOTIVATIONAL INTERVIEWING AND EXAMINING THE ROLE OF E-CIGS
Learning Objectives TOBACCO CESSATION: INCORPORATING MOTIVATIONAL INTERVIEWING AND EXAMINING THE ROLE OF E-CIGS Cheyenne Newsome, PharmD PGY2 Ambulatory Care Resident University of New Mexico College of
More informationSmoking Cessation Strategies in 2017
Smoking Cessation Strategies in 2017 Robert Schilz DO, PhD, FCCP Division of Pulmonary, Critical Care and Sleep Medicine Director of Lug Transplantation University Hospitals of Cleveland Case Western University
More informationTOBACCO CESSATION: INCORPORATING MOTIVATIONAL INTERVIEWING AND EXAMINING THE ROLE OF E-CIGS
TOBACCO CESSATION: INCORPORATING MOTIVATIONAL INTERVIEWING AND EXAMINING THE ROLE OF E-CIGS Cheyenne Newsome, PharmD PGY2 Ambulatory Care Resident University of New Mexico College of Pharmacy Learning
More informationTobacco treatment for people with serious mental illness (SMI)
Tobacco treatment for people with serious mental illness (SMI) An opportunity to close the mortality gap Massachusetts Mental Health Center 1 National Resource Center for Academic Detailing A compelling
More informationSmoking Cessation A Clinicians Perspective. Jeff Wilson, MD
Smoking Cessation A Clinicians Perspective Jeff Wilson, MD Overview Tobacco control what we have accomplished and the road ahead Role of the health care professional Using pharmacotherapy Electronic cigarettes
More informationTRENDS IN TOBACCO UNDERSTAND 5/26/2017 LEARNING OBJECTIVES. Understand the types of tobacco products trending in today s market & associated risks
TRENDS IN TOBACCO And What Employers Can Do to Support Cessation Katy Tombaugh, Certified Tobacco Treatment Specialist Founder & CEO, Wellness Collective LEARNING OBJECTIVES Understand the types of tobacco
More informationClearing the Air: What You Need to Know and Do to Prepare to Quit Smoking
Clearing the Air: What You Need to Know and Do to Prepare to Quit Smoking Getting Ready to Quit Course Creating Success! THINK ABOUT Process of Changing an Addiction Your Pros and Cons of Smoking and Quitting
More informationDispensing of Nicotine Replacement Therapy (NRT)
Simcoe Muskoka District Health Unit Print Version Medical Directive Number: Topic: Dispensing of Nicotine Replacement Therapy (NRT) Revised: October 2011 Approved: May 21, 2007 Description Nicotine Replacement
More informationEVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO
EVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO Lena Matthias Gray, MSA, CTTS-M University of Michigan MHealthy Tobacco Consultation Service Overview of Tobacco Use The World Health Organization
More informationDERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC)
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) Derbyshire Formulary for Nicotine Replacement Therapy (NRT) 1. Supporting Smokers to stop smoking The most effective method to quit smoking is by quitting
More informationWHAT IS THE GUIDELINE
WHAT IS THE GUIDELINE WHAT IS THE GUIDELINE Treating Tobacco Use and Dependence, a Public Health Service Clinical Practice Guideline, is the result of an extraordinary partnership among Federal Government
More informationChantix (Varenicline) and Risk of Cardiovascular Events
PL Detail-Document #270803 This PL Detail-Document gives subscribers additional insight related to the Recommendations published in PHARMACIST S LETTER / PRESCRIBER S LETTER August 2011 Chantix (Varenicline)
More informationTobacco use assessment, brief counseling,, and quit line referral
Tobacco use assessment, brief counseling,, and quit line referral What is the evidence for tobacco cessation counseling? Tobacco use is the leading cause of preventable death in the US 1 Counseling and
More informationChantix Label Update 2018
Chantix Label Update 2018 Chantix (varenicline) Prescribing Information Chantix Prescribing Info URL and Disclaimer Please refer to the full Prescribing Information on important treatment considerations
More informationSetting the Stage: Tobacco s Impact on Smokers, Employers, and Florida
Setting the Stage: Tobacco s Impact on Smokers, Employers, and Florida Thomas H. Brandon, Ph.D. H. Lee Moffitt Cancer Center & Research Institute Florida Tobacco Cessation Summit October 14, 2010 Moffitt
More informationTITLE DEPARTMENT OF BUSINESS REGULATIONS
230-RICR-20-30-12 TITLE 230 - DEPARTMENT OF BUSINESS REGULATIONS CHAPTER 20 - INSURANCE SUBCHAPTER 30 - HEALTH INSURANCE PART 12 - Tobacco Cessation Treatment Coverage 12.1 Preamble A. According to the
More informationUnitedHealthcare Pharmacy Clinical Pharmacy Programs
UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2017 P 2045-6 Program Prior Authorization/HCR- Tobacco Cessation - Health Care Reform Medication Bupropion SR (generic Zyban), Chantix
More informationPractical Skills for Working with your Patients who Smoke. Daryl Sharp, PhD, APRN, BC, FNAP University of Rochester
Practical Skills for Working with your Patients who Smoke Daryl Sharp, PhD, APRN, BC, FNAP University of Rochester 1 Epidemiology: Smoking and Mental Illness People with serious mental illness die, on
More informationTobacco Cessation: Priority for Health Providers. Acknowledgements. Tobacco Cessation: Secondhand Smoke. Smoke-Free Environment & CA
Acknowledgements Smoking Cessation Leadership Center http://smokingcessationleadership.ucsf.edu/ Rx for Change http://rxforchange.ucsf.edu/ Tobacco Use and Dependence: 2008 Update http://www.surgeongeneral.gov/tobacco
More informationThe Kentucky Department for Public Health University of Kentucky College of Nursing Local Health Department Tobacco Cessation Survey, 2007
The Kentucky Department for Public Health University of Kentucky College of Nursing Local Health Department Tobacco Cessation Survey, 2007 District Health Department Report prepared through a contract
More informationKicking the Habit Pharmacological Help for Smokers
Kicking the Habit Pharmacological Help for Smokers Catherine E. Cooke, PharmD, BCPS, PAHM Independent Consultant Clinical Assistant Professor, Univ. of Maryland Special Thanks to Teisha Robertson, PharmD
More informationThe Interaction of Depression and Smoking following ACS Andrew M. Busch, PhD
The Interaction of Depression and Smoking following ACS Andrew M. Busch, PhD Senior Psychologist, Dept. of Medicine, HCMC Associate Professor, Dept. of Medicine, University of MN Disclosures No conflicts
More informationExecutive Summary. Context. Guideline Origins
Executive Summary Context In America today, tobacco stands out as the agent most responsible for avoidable illness and death. Millions of Americans consume this toxin on a daily basis. Its use brings premature
More informationTobacco Cessation Best Practices: Pharmacotherapy
Tobacco Cessation Best Practices: Pharmacotherapy Please do the following Housekeeping Turn off or mute your computer speakers. Mute your phone by dialing *6* (dial *6* again to unmute yourself) Copy this
More informationTobacco Cessation, E- Cigarettes and Hookahs
Objectives Tobacco Cessation, E- Cigarettes and Hookahs Discuss evidence-based tobacco cessation interventions including pharmacologic options. Review e-cigarette and hookah facts and safety considerations.
More informationTobacco Use & Dependence. Dr. Mohammad Taraz Clinical Pharmacist July 2012
Tobacco Use & Dependence Dr. Mohammad Taraz Clinical Pharmacist July 2012 Introduction As a major risk factor for a wide range of diseases, including cardiovascular conditions, cancers, & pulmonary disorders,
More informationDrug Use Evaluation: Smoking Cessation
Drug Use Research & Management Program Oregon State University, 3303 SW Bond Av CH12C, Portland, Oregon 97239-4501 Phone 503-947-5220 Fax 503-494-1082 Drug Use Evaluation: Smoking Cessation Tobacco cessation
More informationA systems approach to treating tobacco use and dependence
A systems approach to treating tobacco use and dependence Ann Wendland, MSL Policy Analyst & Cessation Programs Manager NYSDOH Bureau of Tobacco Control ann.wendland@health.ny.gov A systems approach to
More information4/2/2015. Inpatient Smoking Cessation. Smoking Cessation Documentation Patient's Stage of Behavior Change
Implementing Updates Barbara Darsow COTA/BA, CES TEAM Project: Promoting in Hospital Patients 1996 Smoke Free 2000 Coalition Completed Training Smoking cessation counselor at Mayo Clinic Tobacco research
More informationNICOTINE PHARMACOLOGY and PRINCIPLES of ADDICTION. 3 rd of 3 Prep for Session 1
NICOTINE PHARMACOLOGY and PRINCIPLES of ADDICTION 3 rd of 3 Prep for Session 1 CHEMISTRY of NICOTINE Pyridine ring N H N CH 3 Pyrrolidine ring Nicotiana tabacum Natural liquid alkaloid Colorless, volatile
More informationClosing the Gap: Treatment of Tobacco Dependence
Closing the Gap: Treatment of Tobacco Dependence Disclosure of Relevant Financial Relationships With any entity producing, marketing, re-selling, or distributing health care goods or services consumed
More informationTRAINING FRONTLINE STAFF
FRONTLINE STAFF TRAINING FRONTLINE STAFF Frontline staff are essential to ensuring that tobacco users are identified at every clinical visit so they can be provided with lifesaving tobacco cessation interventions.
More informationUPDATE TREATMENT OF TOBACCO USE DISORDERS
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences UPDATE TREATMENT OF TOBACCO USE DISORDERS MARK DUNCAN MD UNIVERSITY OF WASHINGTON OBJECTIVES 1. Remind everyone
More informationNicotine Replacement Therapy (NRT).
Nicotine Replacement Therapy (NRT). Information for smokers 1 What is NRT? The aim of Nicotine Replacement Therapy (NRT) is to reduce the withdrawal symptoms associated with nicotine addiction by replacing
More informationTobacco Cessation for Women of Reproductive Age. Erin McClain, MA, MPH
Tobacco Cessation for Women of Reproductive Age Erin McClain, MA, MPH Tobacco Use During Pregnancy in NC 2 1 in 10 babies in NC are born to women reporting tobacco use during pregnancy In some counties
More informationAn Evolving Perspective on Smoking Cessation Therapies
An Evolving Perspective on Smoking Cessation Therapies Andrew Pipe, CM, MD Chief, Division of Prevention & Rehabilitation University of Ottawa Heart Institute Faculty/Presenter Disclosure Andrew Pipe,
More informationCommon Diagnosis Codes and Tips for Coding Nicotine Use/
ICD-10 Tobacco Billing Guide ICD-10 and Tobacco Common Diagnosis Codes and Tips for Coding Nicotine Use/ Dependence Tobacco use is the leading cause of preventable disease and death in the United States,
More information